[Other] Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial |
|
This post will be closed automatically in 2026-07-03 14:10
Reward10points
|
post
reply
points
34341
20
Hypersonic Glide Vehicle Trajectory Forecasting via Transformer and Physics-Informed GBDT Models
10
Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder
10
Enhanced Performance of BK7-Ag-WS₂-Ni-Graphene Surface Plasmon Resonance Sensor for Glucose Detection in Urine
20
Linking Perceived Corporate Social Responsibility to Brand Advocacy Through Trust and Brand Equity
40
A ※Kind Harshness§
